Evidence map›Paper›PMID 30258105›Full record

ArticleScientific reports2018

Biolistic-delivery-based transient CRISPR/Cas9 expression enables in planta genome editing in wheat.

Haruyasu Hamada, Yuelin Liu, Yozo Nagira, Ryuji Miki, Naoaki Taoka, Ryozo Imai

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed.

  1. Wheat's Up with CRISPR-Cas-Current Advances, Obstacles and Perspectives.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Article
  4. Development ofFrontiers in genome editing · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. CRISPR-Cas applications in agriculture and plant research.Nature reviews. Molecular cell biology · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Frontiers in plant science · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Haruyasu HamadaBiotechnology Research Laboratories, KANEKA CORPORATION, Takasago, Japan.
Yuelin LiuDivision of Applied Genetics, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, 2-1-2 Kannondai, Tsukuba, 305-8602, Japan.
Yozo NagiraBiotechnology Research Laboratories, KANEKA CORPORATION, Takasago, Japan.
Ryuji MikiBiotechnology Research Laboratories, KANEKA CORPORATION, Takasago, Japan.
Naoaki TaokaBiotechnology Research Laboratories, KANEKA CORPORATION, Takasago, Japan.
Ryozo ImaiDivision of Applied Genetics, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, 2-1-2 Kannondai, Tsukuba, 305-8602, Japan. rzi@affrc.go.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current application of genome editing to crop plants is limited to cultivars that are amenable to in vitro culture and regeneration. Here, we report an in planta genome-editing which does not require callus culture and regeneration. Shoot apical meristems (SAMs) contain a subepidermal cell layer, L2, from which germ cells later develop during floral organogenesis. The biolistic delivery of gold particles coated with plasmids expressing CRISPR/Cas9 components designed to target TaGASR7 were bombarded into SAM-exposed embryos of imbibed seeds. Bombarded embryos showing transient GFP expression within SAM were selected and grown into adult plants. Mutations in the target gene were assessed in fifth-leaf tissue by cleaved amplified polymorphic sequence analysis. Eleven (5.2%) of the 210 bombarded plants carried mutant alleles, and the mutations of three (1.4%) of these were inherited in the next generation. Genotype analysis of T

Indexed as

CRISPR-Cas SystemsBiolisticsGene EditingMeristemMutagenesisMutationPlants, Genetically ModifiedRNA, Guide, CRISPR-Cas SystemsTriticumRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID30258105
PMCPMC6158239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.